Pfizer Defends IP For New Version Of Pneumonia Vaccine
Pfizer Inc. has pushed back at Merck Sharp & Dohme Corp.'s latest patent challenge to the U.S. drugmaker's popular Prevnar 13 pneumonia vaccine, arguing that its intellectual property was not obvious....To view the full article, register now.
Already a subscriber? Click here to view full article